Delivery Order SPE2DB24D1021-SPE2DB25FEWCT

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 100 capsules of the medication Tacrolimus 0.5 mg (immediate release) to the Defense Logistics Agency (DLA). The contract, a firm fixed-price delivery order valued at $1,856.62, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of October 21,...
This federal contract award, valued at $1,221.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a prescription medication. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen holds a...
This federal contract award, valued at $2,058.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a pharmaceutical product, with a completion date of December 23, 2024. The contract has a Firm Fixed Price pricing type and is a Delivery Order, not associated with a larger contract vehicle. The contract does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,925.04, is for the delivery of TACROLIMUS 0.5 MG CAPSULE (IR) 100S, a generic pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 15, 2024 and is structured as a Firm Fixed Price Delivery Order. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,698.59, is for the delivery of 100 units of the medication Tacrolimus 5 mg capsules. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 30, 2023. There is no set-aside designation associated with this award. AmerisourceBergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,581.16, is for the delivery of Tacrolimus 1 mg capsules (immediate-release) in 100-count containers. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 21, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,622.72, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a medication used in transplant patients. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,541.84, is for the delivery of Tacrolimus 5 mg capsules to support military healthcare programs. The award is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,550.49 firm-fixed-price delivery order is for the supply of 100 capsules of the drug Tacrolimus 1 mg, which is used for immunosuppression. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,474.11 firm fixed-price delivery order is for the supply of 100 capsules of 5 mg Tacrolimus (an immunosuppressant medication). The contract has an ultimate completion date of July 15, 2024 and was awarded on July 12, 2022. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEWCT
    Delivery Order

This federal contract award, valued at $2,201.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,567,996,433 units of the medication Tacrolimus 5 mg Capsule (IR) 100s, with a completion date of April 23, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This award demonstrates Amerisourcebergen's capacity to fulfill diverse federal medical supply requirements, particularly for military and veteran healthcare systems.

Generated 7/22/25, 10:02 AM